middle.news
How BlinkLab’s $3.76M Loss Fuels Breakthroughs in Autism and ADHD Diagnostics
10:24am on Wednesday 25th of February, 2026 AEDT
•
Healthcare
Read Story
How BlinkLab’s $3.76M Loss Fuels Breakthroughs in Autism and ADHD Diagnostics
10:24am on Wednesday 25th of February, 2026 AEDT
Key Points
Net loss increased 68% to $3.76 million for half-year ended December 2025
Completed large U.S. autism pilot study with strong diagnostic accuracy
Expanded U.S. clinical trial sites and advanced European ADHD study
Ongoing regulatory engagement with FDA for pivotal 510(k) submission
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
BLINKLAB (ASX:BB1)
OPEN ARTICLE